Need professional-grade analysis? Visit stockanalysis.com
$434.93M
N/A
N/A
N/A
Century Therapeutics Inc (IPSC) trades on United States in USD. The company is classified in the Healthcare sector under the Biological Products industry. The stock currently trades at $2.30, down 11.54% from the previous close.
Over the past year, IPSC has traded between a low of $0.46 and a high of $2.73. The stock has gained 325.9% over this period. It is currently 15.8% below its 52-week high.
Century Therapeutics Inc has a market capitalization of $434.93M.
Century Therapeutics, Inc., a biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases. Its lead product candidate is CNTY-813, an iPSC-derived beta islet cell replacement therapy engineered with Allo-Evasion 5.0 for the treatment of type 1 diabetes. The company is also involved in the development of CNTY-308, a CD19-targeted CD4+/CD8+ CAR-iT cell therapy engineered with Allo-Evasion 5.0 as a potential treatment for B-cell-mediated autoimmune diseases; and CNTY-101, an allogeneic, iPSC-derived CAR-iNK cell therapy with six precision gene edits engineered to express CD19 CAR, with Allo-Evasion 1.0 edits designed for the treatment of CD19 for B-cell mediated autoimmune diseases. Century Therapeutics, Inc. was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.
Side-by-side comparison against top Healthcare peers.